OPRX — OptimizeRx Corp
—
Nasdaq ·
Industrials ·
Professional Services ·
CIK 1448431 ·
Last close
$8.04
Market Cap
$151.44M
52W High
$22.25
52W Low
$4.54
ADV30
171,067
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 20,504,000 | 15,688,000 | -88,000 | -703,000 | 164,317,000 | 24,096,000 | 33,235,000 |
| Mar 2026 | 19,844,000 | 14,932,000 | 396,000 | -495,000 | 167,264,000 | 20,169,000 | 37,653,000 |
| Dec 2025 | 32,239,000 | 24,100,000 | 8,937,000 | 5,020,000 | 176,918,000 | 23,365,000 | 48,624,000 |
| Sep 2025 | 26,067,000 | 17,516,000 | 2,050,000 | 779,000 | 170,321,000 | 19,519,000 | 48,058,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$14,384,000
Investing CF
$131,000
Financing CF
$-10,919,000
CapEx
$-159,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$0.35
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-79,731,000
Inventory
—
Receivables
$32,860,000
ST Investments
—
EBIT TTM
$14,742,000
Pretax Income TTM
$9,589,000
Interest Exp TTM
$5,153,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$98,654,000
EBITDA
$15,551,000
Free Cash Flow
$15,760,875
Enterprise Value
$132,698,080
Total Cash
$24,096,000
Total Debt
$19,480,000
Shares Out
18,835,951
Trailing EPS
$0.25
Book Value
$6.96
ROE
3.7%
ROA
4.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 109,429,000 | 12,061,000 | 5,132,000 | 176,918,000 | 48,624,000 | 128,294,000 | 18,715,000 |
| Dec 2024 | 92,127,000 | -6,217,000 | -20,110,000 | 171,168,000 | 54,170,000 | 116,998,000 | 4,889,000 |
| Dec 2023 | 71,522,000 | -17,522,000 | -17,566,000 | 183,374,000 | 56,821,000 | 126,553,000 | -7,240,000 |
| Dec 2022 | 62,450,156 | -12,290,738 | -11,438,440 | 134,651,185 | 8,540,408 | 126,110,777 | 10,654,078 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$43,237,000
NetIncome TTM
$-11,323,000
OpCashFlow TTM
$0
Assets (Latest)
$176,918,000
Forward EPS
$1.06
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $7.77 · call volume: 4 · put volume: 100
Expected Move to 2026-10-16:
±$1.20
(15.43%) —
implied range
$6.57 –
$8.97
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XHLD | TEN Holdings, Inc. | $155.14M | $12.95 | — |
| RGP | RESOURCES CONNECTION, INC. | $130.54M | $3.79 | — |
| DVLT | Datavault AI Inc. | $128.17M | $0.15 | — |
| ICTSF | ICTS INTERNATIONAL N V | $202.81M | $5.89 | — |
| DHX | DHI GROUP, INC. | $204.33M | $4.73 | — |
News headlines (Yahoo Finance, 1h cache)
OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network
2026-09-22 17:18 · Yahoo
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
2026-09-22 12:00 · Yahoo
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
2026-09-14 12:00 · Yahoo
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
2026-09-08 11:30 · Yahoo
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
2026-09-02 11:30 · Yahoo
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript
2026-08-19 23:44 · Yahoo
OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...
2026-08-13 05:03 · Yahoo
OptimizeRx Q2 Earnings Call Highlights
2026-08-13 01:04 · Yahoo
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates
2026-08-12 21:40 · Yahoo
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
2026-08-12 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.